Bengt Hedin

Senior Consultant

With more than 20 years of experience in the Life Sciences industry, Bengt has a vast understanding of drug development with a focus on pediatric medicine. While his expertise lies within formulation development, he has also worked in process development and small-scale manufacturing of most dosage forms from the early phase, during registration and life cycle management post-authorization, covering small molecules, peptides, and biologics.

Bengt has worked with EMA and the FDA, and other regulatory authorities globally during clinical trial applications and market authorizations, and as an expert within EDQM and the Swedish Medical Product Agency. He joined Cytel in 2022.

Bengt has a Master’s degree in Pharmaceutics from Uppsala University.